The Role of Technology in Newborn Screening.

Journal Article (Journal Article)

This commentary traces the expansion of newborn screening for inherited metabolic disorders during the past 55 years, from the first simple test for phenylketonuria to the current panel of over 35 conditions. Emphasis is placed on the role played by technology and the contributions made by researchers in North Carolina.

Full Text

Duke Authors

Cited Authors

  • Millington, DS

Published Date

  • 2019

Published In

Volume / Issue

  • 80 / 1

Start / End Page

  • 49 - 53

PubMed ID

  • 30622207

International Standard Serial Number (ISSN)

  • 0029-2559

Digital Object Identifier (DOI)

  • 10.18043/ncm.80.1.49


  • eng

Conference Location

  • United States